Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy

Journal of Thoracic Oncology

Volumn 4, Issue 12, 2009, Pages 1590-1591

  Gore, Elizabeth ^a   Currey, Adam ^a   Choong, Nicholas ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CONTRAST MEDIUM; GEMCITABINE; PACLITAXEL;

ADULT; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRICOID; DYSPHAGIA; ESOPHAGOGASTRODUODENOSCOPY; HUMAN; LETTER; LUNG BIOPSY; LUNG COLLAPSE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MALE; MEDIASTINOSCOPY; MULTIPLE CYCLE TREATMENT; PLEURA CAVITY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; SALVAGE THERAPY; STENT; TRACHEOESOPHAGEAL FISTULA;

EID: 74249111560     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181c06a6f     Document Type: Letter

References (5)

1. Ahn SJ, Kahn D, Zhou S, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005;61:335-347.
2. Spigel DR, Hainsworth JD, Farley C, et al. Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limitedstage small-cell lung cancer (LS-SCLC). J Clin Oncol 2008;26 (May 20 suppl; abstr 7554).
3. Seiwert TY, Haraf DJ, Cohen EE, et al. Phase I study of bevacizumab added to fluorouraciland hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. J Clin Oncol 2008;26:1732-1741.
4. Important drug warning regarding Avastin. Available at: http://www.fda.gov/medwatch/ safety/2007/Avastin-DHCP-TEF-Final- April2007.pdf. Accessed May, 2009.
5. Goodgame B, Veeramachaneni N, Patterson A, Govindan R. Tracheo-esophageal fistula with bevacizumab after mediastinal radiation. J Thorac Oncol 2008;3:1080-1081.